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Abstract
VASA, also known as DDX4, is reported to be speciﬁcally expressed in cells belonging to the germ cell lineage, both in males and
females. Therefore, it could be an informative protein biomarker to be applied on semen to differentiate between obstructive and
nonobstructive azoospermia (OA and NOA, respectively). In addition, it could be of value to predict sperm retrieval based on testicular
sperm extraction. Immunocytochemistry of proven OA semen using both polyclonal and monoclonal antibodies against VASA
showed positive staining of both cells and cell sized particles. This is spite of being the absolute negative controls, completely lacking
germ lineage derived cells and material. In order to identify the source of the VASA-positive material, a detailed screen of different
anatomical parts of the whole male urogenital tract was performed of multiple cases using immunohistochemistry.
The polyclonal antibody stained, besides the expected germ cells in the testis, epithelium of the bladder and the seminal vesicles.
The monoclonal antibody only stained the latter. To investigate whether the immunohistochemical staining is associated with the
presence of the corresponding VASA mRNA, samples of seminal vesicles, bladder, testis, and semen (with and without germ cells)
were investigated using the speciﬁc quantitative reverse transcription-polymerase chain reaction (qRT-PCR) on 42 samples. A
positive result was detected in testis and semen containing germ cells (n=10 and 8), being negative in semen without germ cells (n=
11), bladder (n=3), and seminal vesicles (n=10).
Two commercially available VASA antibodies (mono- and polyclonal) are not speciﬁc. In contrast, VASA-mRNA evaluation, using
qRT-PCR, is speciﬁc for the presence of germ cells, therefore, is an interesting molecular biomarker for germ cell detection in semen.
Abbreviations: FFPE = formalin-ﬁxed parafﬁn-embedded, GCNIS = germ cell neoplasia in situ, IC = immunocytochemistry, ICSI
= intra cytoplasmatic sperm injection, IHC = immunohistochemistry, MVH = mouse vasa homolog, NOA = nonobstructive
azoospermia, OA = obstructive azoospermia, qRT-PCR = quantitative reverse transcription-polymerase chain reaction, TESE =
testicular sperm extraction.
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In males and females, human VASA (DDX4) is the only reported
gene speciﬁcally expressed in the germ cell lineage both during
embryonic development and postnatally. So far themRNAVASA
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1during embryogenesis. The vas gene was originally identiﬁed in
Drosophila (vasa), later in the mouse (Mouse vasa homolog,
MVH) and in humans (VASA).[2–7] It maps on chromosome 5q
and encodes a DEAD-box protein with ATP-dependent RNA-
helicase activity.[4,8] This gene is also referred to as DEAD-box
helicase 4 gene (DDX4). As male MVH knock-out mice are
infertile without other anomalies, VASA seems to play an
essential role in male fertility speciﬁcally.[6]
VASA can differentiate testicular biopsies from men with
obstructive azoospermia (OA) and nonobstructive azoospermia
(NOA) using immunohistochemistry and quantitative reverse
transcription-polymerase chain reaction (qRT-PCR). In fact,
VASA shows different expression levels depending on the
azoospermic etiology.[9] Men with NOA can only father a child
after intracytoplasmatic sperm injection (ICSI) with their
surgically harvested testicular sperm cells (Testicular Sperm
Extraction,TESE).[10] TESE will yield spermatozoa in 50% of the
patients with NOA.[11] It would be very useful to be able to
predict which patients would beneﬁt from TESE and so prevent
patients from undergoing a useless operation for obtaining
sperm. It is also reported that in segregated ejaculated
spermatozoa VASA can distinguish fertile from infertile men
both on mRNA and protein level.[12] Moreover, in cell-free
seminal plasma from ejaculates of patients with azoospermia,
Boellaard et al. Medicine (2017) 96:30 MedicineVASA-mRNA detection could differentiate between certain
etiologies of NOA.[13] In conclusion, VASA is an interesting
potential marker to be further investigated in men with NOA.
VASA immunochemistry has been used to detect germ cells in
tissue sections of testis,[9] but not in semen. We wanted to
investigate whether VASA immunocytochemistry (IC) could be
used to differentiate between semen of azoospermic men with OA
and NOA. The aim of the current study was to test the speciﬁcity
of commercially available VASA antibodies for staining of semen
containing germ cells. In addition, the nonspeciﬁcity found was
further evaluated by investigation of different parts of the male
urogenital tract that may shed cells and derived material into
seminal ﬂuid. To this end, a detailed VASA protein analysis was
performed using IC on various semen samples and the different
anatomical parts of the urogenital tract using immunohistochem-
istry (IHC), followed by testing of the speciﬁcity of IC-
demonstrated expression using VASA-mRNA qRT-PCR.2. Materials and methods
Patients gave their verbal consent that left over material, after a
diagnostic procedure, can be used for scientiﬁc purposes. This
agreement is not documented, as agreed upon for this study by
the Erasmus MC institutional review board (ﬁle number medical
ethical committee approval MEC-2013-170). If patients chose to
not consent, it is speciﬁcally indicated in the clinical ﬁles, and
samples were excluded. This consent procedure was used
according to the “Code for Proper Secondary Use of Human
Tissue in the Netherlands.”
The antibodies for VASA, polyclonal Abcam concentration 1
mg/mL ab13840 (Cambridge, UK) and monoclonal Abcam
ab27591, used in this study were selected based on performance
in IHC of the testis in a previous study.[5,14]
The semen samples of OA and NOA were allowed to liquefy
after production and thereafter dissolved in 10% phosphate-
buffered formalin for 1hour. After ﬁxation, the samples wereFigure 1. Male urogenital tract from kidney to urethra and from testis to urethra. VAS
(VmRNA) results are indicated for each anatomical part.
2centrifuged for 20 minutes at 1600g; then, the pellet was
resuspended in phosphate-buffered saline and vibrated with the
useof anautomatic shaker tomakea single-cell solution.Cytospins
of this suspensionweremadeona strong adhesivemicroscope slide
(Starfrost©) andwere dried overnight. The cytospins were blocked
with 3% H2O2 and after antigen retrieval incubated overnight at
4°C with a polyclonal (Abcam ab13840) DDX4/MVH antibody.
After 30minutes incubation with biotinylated Swine anti Rabbit
(Dako E431, Glostrup, Denmark), the slides were incubated with
Vector ABcpxHRP (Vector 6100, Burlingame, CA). Visualization
was done with 3-amino-9-ethylcarbazole (AEC)/H2O2. A part of
the semen samples were also incubated with a monoclonal
antibody (Abcam ab27591) DDX4/MVH to compare with the
polyclonal antibody in the same assay as described above. As a
secondary antibody, a biotinylated rabbit antimouse antibodywas
used (E0413; Dako). Detection and counterstaining were carried
out as described above.
Formalin-ﬁxedparafﬁn-embedded (FFPE) tissuesof thedifferent
anatomical parts of the urogenital tract, from the pyelocaliceal
system to urethra and from seminiferous tubules to prostatic
urethra, were obtained from 6 males who underwent various
surgical procedures. In total 2 representative sets of the complete
male urogenital tract were composedwith at least 2 andmaximum
6 tissue blocks containing kidney, pyelocaliceal system, ureter,
bladder, urethra, testis, epididymis, vas deferens, seminal vesical,
ejaculatory duct, prostate, and prostatic urethra (see Fig. 1 for
summary). Additionally, the FFPE tissues from seminal vesicles
obtained fromprostatectomy specimens of 6 patientswith prostate
cancer without prior treatment besides surgery were included. The
tissues were stained with HE and IHC by using respectively
polyclonal (Abcam ab13840) and monoclonal (Abcam ab27591)
DDX4/MVH antibodies. After deparafﬁnization, IHC was
performed as described for the cytospin samples. Cytokeratin 8
(CAM5.2, B&D 347205; BD Biosciences, San Jose, CA) staining
was applied, by the same method as described above, to
differentiate germ cells from epithelial cells and cell fragments.A immunohistochemistry (mono- and polyclonal; Vm and Vp) and VASAmRNA
-dCt
Figure 2. Staining of testis, epididymis, and semen using monoclonal (A, B, C) and polyclonal (D–F) VASA antibody. In the testis (A and D), all cells of germ lineage
except elongated spermatids and spermatozoa show cytoplasmatic staining; no other cell types are positive. Epididymal epithelium is VASA-negative whereas
some germ cells in the lumen show cytoplasmic staining (B and E). Semen from a patient with obstructive azoospermia (C) and from a patient with nonobstructive
azoospermia (F) shows positive staining of unidentiﬁed material including cell-sized particles and occasional cells.
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To verify the speciﬁcity of VASA IC in germ cells, bladder and
seminal vesicle epithelium high quality total RNA was extracted
from normal testis-parenchyma (n=10), semen of men with
normospermia (n=8), NOA (n=5), OA (n=6), bladder (n=3),
and seminal vesicles (n=10) using TRIzol Reagent (Life
Technologies, Bleiswijk, the Netherlands) according to the
manufacturer’s instructions. qRT-PCR was performed in dupli-
cate using mRNA probes VASA hs00987125_m1 and endoge-
nous control hypoxanthine-guanine phosphoribosyltransferase
(HPRT)1 (4333768F; Life Technologies). Relative VASAFigure 3. Epithelial staining in the seminal vesicle (left) and bladder (right) by polyc
bladder, only sporadically weak staining of the luminal surface (shown here) by m
3transcript abundance was calculated using the 2 method
(VASA mRNA= mean Ct HPRT –mean Ct VASA) as described
before.[15]
3. Results
VASA IC staining of semen in bothmultipleOAandNOAsamples
(n=57 and n=98, respectively) showed inconsistent results with,
sometimes even abundant, positivity in semen samples of patients
with OA. The positive material included cells and cell sized
particles which were difﬁcult to distinguish from cells, both using
the polyclonal or the monoclonal antibodies (Fig. 2, panels C andlonal VASA antibody (A, B) and in seminal vesicle (left) and virtually negative in
onoclonal VASA antibody (C, D).
Figure 5. VASA mRNA expression proﬁle (relative to HPRT) in normal testis
parenchyma, semen of men with normospermia (NS), nonobstructive
azoospermia (NOA), obstructive azoospermia (OA), seminal vesicles (sv),
and bladder. HPRT=hypoxanthine-guanine phosphoribosyltransferase, NOA
=nonobstructive azoospermia, NS = normospermia, OA=obstructive azoos-
permia, sv = seminal vesicles.
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NOA. In patients with OA, the staining material is obviously not
derived from the germ lineage, as their ejaculate does not contain
germ cells or derivatives (i.e., negative control). IHC with the
polyclonal antibody against VASA showed protein expression in
germcells of the testis (Fig. 2, panel A), as expected, and in addition
staining of the epithelial cells of the seminal vesicles and the bladder
(Fig. 3, panels A andB).No stainingwas found in the other parts of
the urogenital tract: kidney, renal pelvis, ureter, urethra,
epididymis, vas deferens, and prostate were all VASA-negative
(Fig. 1). Themonoclonal VASA antibody showed a similar pattern
for testis (Fig. 2, panel D) and seminal vesicle (Fig. 3, panel C).
However, bladder epithelial cells remained virtually negative with
only sporadicallyweakstainingof the luminal surface (Fig. 3, panel
D).Byomitting theprimaryantibody, therewasno staining at all in
IC and IHC (data not shown).
Staining of seminal vesicle epithelium with the monoclonal
VASA antibody was reproduced in FFPE tissue samples of 6Figure 4. Seminal vesicle: (A) HE staining; (B) VASA monoclonal antibody
staining showing positivity of the epithelium and abundant VASA-positive
material in the lumen including virtually all sized particles and nucleated cells.
This material is most likely the source of the VASA positive material in semen of
patients with OA and NOA. (C) Cytokeratin-8 stains the epithelium and some of
the cells in the lumen. Such cells may be confused with immature germ cells in
VASA immunocytochemistry of semen. HE=hematoxyline-eosine, NOA=
nonobstructive azoospermia, OA=obstructive azoospermia.
4seminal vesicles, obtained from prostatectomy specimens (Fig. 4,
panel B). All showed a similar expression pattern with strong
staining in the periphery of the vesicle and weak to absent
staining more centrally. Virtually all material in the lumen of the
seminal vesicles showed strong VASA staining. It consists of
amorphous material, cell-sized particles and cells with recogniz-
able nuclei, obviously shed from the seminal vesicle epithelium.
Occasional intact cells in the lumen express Cytokeratin 8 like the
epithelial cells of the seminal vesicle (Fig. 4, panel C), suggesting
that IC-VASA-positive non-germ cells may rarely occur in semen.
Noteworthy, the morphology of the VASA-positive material in
semen (Fig. 2, panels C and F) and in the lumen of seminal vesicles
(Fig. 4, panel B) is highly similar.
To further investigate the speciﬁcity of the ﬁndings, a
molecular analysis based on qRT-PCR was performed on a
series of 42 samples of multiple origins. In all germ cell containing
testis, parenchyma samples and normal sperm samples VASA
mRNA were detected (Fig. 5 and supplemented Figure 1, http://
links.lww.com/MD/B809). Expression of VASA in the case of
NOA depended on the presence of germ cells in the testis. In
addition, VASA mRNA was detected in semen of 4 men with
maturation arrest of spermatogenesis. The only sample lacking
VASA expression was related to a man diagnosed with complete
Sertoli cell only syndrome (i.e., devoid of germ cells). In semen of
patients with OA, VASA mRNA was in all cases undetectable,
consistent with the clinical diagnosis. Moreover, VASA mRNA
was detected in none of the 10 seminal vesicles nor in the 3
bladder samples, indicating that the immunohistochemical
staining in the epithelium and lumen of seminal vesicles and
the bladder epithelium is not related to the presence of VASA
protein (Fig. 1).
4. Discussion
In males and females, VASA protein is present in the cytoplasm of
all cells of the germ lineage, both during embryonic development
and postnatally. In the testis, spermatocytes show the highest
VASA expression and the strongest IHC staining. Spermatids also
have a clear expression with strong staining. Spermatogonia
show either weak or intermediate staining which may correspond
with type A or B spermatogonia. In spermatozoa, VASA protein
is only detectable by immunoﬂuorescense on unﬁxed material
because of its low expression level. Sertoli cells are negative for
the VASA protein.[4,5,8,12] VASA is also expressed in seminoma,
dysgerminoma, their respective precursor lesions germ cell
neoplasia in situ (GCNIS) and gonadoblastoma and in
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these tumors.[5] Our results of IHC of normal testis concur with
these literature data (Fig. 2). These data are in line with other
ﬁndings, summarized online (http://www.genecards.org/cgi-bin/
carddisp.pl?gene=ddx4).
Using the Northern blot assay, Castrillion and coworkers
examined VASA expression in testis, ovary, prostate, brain,
thymus, lung, liver, spleen, pancreas, small intestine, colon,
stomach, kidney, adrenal, placenta and peripheral blood leuko-
cytes, and concluded that VASA expression was undetectable in
nongonadal tissues.[4] In contrast, here we show that immunohis-
tochemistry with a commercially available polyclonal VASA
antibody not only stains germ cells in testis but also epithelial
cells of the bladder and the seminal vesicle (Fig. 3). In addition, a
commercially available monoclonal VASA antibody also stains
germ cells and the epithelial cells of the seminal vesicle, although
overall thebladder isnegative (Fig. 3, panelCandD;Fig. 4panelB).
In addition to the protein analyses, qRT-PCR on a series of 42
independent samples was performed, showing that the protein
staining does not correspond to VASA. Although this is a limited
number of samples, the results are consistent and show little
variability. The results indicate that the VASAmRNA expression
is indeed found only in germ cells in testis and semen, as well as
epididymis, extending the results of Castrillon and coworkers on
somatic tissues, conﬁrming the speciﬁcity of VASA for germ
cells.[4] The IHC staining of epithelium of the seminal vesicle with
the monoclonal reagent is therefore most likely due to cross-
reaction with protein(s). Material positive for this signal is
abundantly shed in the lumen of seminal vesicles (Fig. 4) and is
probably the source of the material found positive upon IC of
semen in view of the fact that it is also present in the ejaculate of
men with complete OA. The abundance of this material and its
morphology, with cell-sized particles and occasional VASA-
positive nongerm cells which could be confused with immature
germ cells,[16,17] precludes the use of semen IC in the diagnosis
and management of male infertility.
Several studies have explored the use of VASA-detection by IHC
(testicular biopsies [9,18]), immunoﬂuorescence and Western
blotting (isolated spermatozoa [12]) ﬂow cytometry (testicular
biopsies [9]), and VASA mRNA qRT-PCR (testicular biopsies,[18]
isolated spermatozoa,[12] and seminal plasma [13,19]) in the
diagnosis and management of male infertility. The mRNA
expression levels of VASA in testicular tissue obtained from
patients undergoing a TESE procedure showed signiﬁcant
difference in expression depending on the number of germ cells
present and the histological classiﬁcation.[18] The results consis-
tently indicate that detection ofVASAprotein ormRNAcorrelates
with the presence of germ cells in the tested sample and may in a
quantitative measurement reﬂect the number of germ cells present.
The latter is a promising method to assist in the etiological
diagnosis of azoospermia and to predict the success of TESE.
Thus far IC for VASA and VASA mRNA qRT-PCR was to our
knowledge not applied to semen. The results of the present study
discourage the use of immunochemical means of detection of
VASA in semen by the commercially available antibodies, and
support the use ofVASAmRNAdetection for diagnostic purposes.5. Conclusions
The polyclonal and monoclonal VASA antibodies tested are not
speciﬁc for germ cells. On the other hand, VASA-mRNA5expression was only found in testis and semen containing germ
cells. These data, though based on a limited number of samples,
conﬁrm that VASA-mRNA detection is a speciﬁc germ cell
marker for semen analysis, and thus a useful adjunct in the
diagnosis and management of male infertility.Acknowledgments
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